Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide

2011361 citationsJournal Article

Authors

Elise Macho Fernandez · Inserm

V. Valenti · Inserm

Christoph Rockel · University of Konstanz

C. Hermann · University of Konstanz

Bruno Pot · Institut Pasteur de Lille

Ivo G. Boneca · Inserm

Corinne Grangette · Institut Pasteur de Lille

Abstract

The results indicated that PGN and derived muropeptides are active compounds in probiotic functionality and might represent a useful therapeutic strategy in IBD.

Topics & Keywords

Probiotics and Fermented Foods Immune Response and Inflammation Gut microbiota and health

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Gut

Volume 60, Issue 8, pp. 1050-1059

DOI: 10.1136/gut.2010.232918

Field-Weighted Citation Impact: 46.96